The Clorox Company 's ( CLX ) strong revenue
generating capabilities, impressive quarterly beats and an upbeat
outlook facilitated it to record a new 52-week high for the 2nd
time in April.COLGATE PALMOLI (CL): Free Stock Analysis
ReportCLOROX CO (CLX): Free Stock Analysis ReportCAMPBELL SOUP (CPB): Free Stock Analysis ReportDISNEY WALT (DIS): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment
After attaining a 52-week high of $89.33 on Tuesday, Apr 2, shares
of this consumer products company further soared to touch a new
high of $89.66 yesterday. Shares eventually closed at $89.53,
rising 20.8% year to date. The company currently trades at a
forward P/E of 20.6x, at par with the peer group average.
Alongside, companies like Campbell Soup Company (
CPB ), The
Walt Disney Company ( DIS ) and
Colgate-Palmolive Co. ( CL ) crafted new 52-week
highs of $46.54, $60.75 and $119.48, respectively on Tuesday.
Clorox's diversified portfolio of brands positions it well to
generate above-average industry growth amid a challenging
environment. The company's rigorous research & development
process, marketing strategies, financial control, and operating
leverage further strengthen its brands and facilitate it to
generate long-term profitability, which is well evident from its
record of beating the quarterly earnings expectations.
If we look at the company earnings surprise history, Clorox has
surpassed the Zacks Consensus Estimate in the last 9 quarters. In
the last reported quarter, the company's earnings beat the Zacks
Consensus Estimate by 11.1%.
Going forward, Clorox expects to sustain its growth momentum
through market share gains and product innovation. The company
raised its sales growth forecast to 3%-5% for fiscal 2013 from
2%-4% projected earlier.
In fiscal 2013, the company expects operating income margin to
expand 25-50 basis points (bps) on the back of efficient cost
savings, price increases and flat commodity costs. Further, Clorox
raised its fiscal 2013 earnings guidance range to $4.25-$4.35 per
share from the previous range of $4.20-$4.35.
Currently, shares of Clorox maintain a Zacks Rank #2 (Buy).